Antibody-Mediated Inhibition of Fibroblast Growth Factor 19 Results in Increased Bile Acids Synthesis and Ileal Malabsorption of Bile Acids in Cynomolgus Monkeys-Reference-Cited by-同舟云学术

Antibody-Mediated Inhibition of Fibroblast Growth Factor 19 Results in Increased Bile Acids Synthesis and Ileal Malabsorption of Bile Acids in Cynomolgus Monkeys

Published:2012-01-19 Issue:2 Volume:126 Page:446-456
ISSN:1096-0929
Container-title:Toxicological Sciences
language:en
Short-container-title:

Author:

Pai Rama,French Dorothy,Ma Ning,Hotzel Kathy,Plise Emile,Salphati Laurent,Setchell Kenneth D. R.,Ware Joseph,Lauriault Veronique,Schutt Leah,Hartley Dylan,Dambach Donna

Publisher

Oxford University Press (OUP)

Subject

Toxicology

Link

http://academic.oup.com/toxsci/article-pdf/126/2/446/16683794/kfs011.pdf

Reference49 articles.

1. Bile acid sulfation: A pathway of bile acid elimination and detoxification;Alnouti;Toxicol. Sci.,2009

2. Bile acid transporters: Structure, function, regulation and pathophysiological implications;Alrefai;Pharm. Res.,2007

3. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor;Ananthanarayanan;J. Biol. Chem.,2001

4. Cellular regulation of hepatic bile acid transport in health and cholestasis;Anwer;Hepatology,2004

5. The bile salt export pump: Molecular properties, function and regulation;Arrese;Pflugers Arch.,2004

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine fibroblast growth factors in domestic animals;Domestic Animal Endocrinology;2024-10

2. Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization;Inflammation Research;2024-07-10

3. Oleanolic acid improved intestinal immune function by activating and potentiating bile acids receptor signaling in E. coli-challenged piglets;Journal of Animal Science and Biotechnology;2024-05-18

4. Pharmacological modulation of cholesterol 7α-hydroxylase (CYP7A1) as a therapeutic strategy for hypercholesterolemia;Biochemical Pharmacology;2024-02

5. Targeting the FGF19–FGFR4 pathway for cholestatic, metabolic, and cancerous diseases;Journal of Internal Medicine;2024-01-11